Physician profile
Ahmed Sedeek
NPI 1427618511
$15,983.47
in general payments reported to CMS, 2019-2025
6 companies · $15.78 in 2025
The $15.78 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $14K · 2024: $1,533 · 2025: $15.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $14K · Travel and Lodging: $1,998 · Food and Beverage: $435 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $13,500.00 |
| Travel and Lodging | $1,998.31 |
| Food and Beverage | $435.16 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $13,500.00 | 2023 | |
| Atricure, INC. | $1,283.44 | 2024 | |
| Abiomed | $950.85 | 2023-2025 | Impella |
| Edwards Lifesciences Corporation | $172.06 | 2024 | |
| W. L. Gore & Associates, INC. | $50.00 | 2024 | Gore-Tex Vascular Graft |
| Ethicon US, LLC | $27.12 | 2024 | Monocryl, Evarrest, Prolene |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Sedeek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.